NAB First-Half Earnings Miss Forecasts Amid Rising Global Risks 
Lufthansa Q1 Loss Narrows as Strong Summer Travel Demand Boosts Outlook 
Rivian Hints at New R2 Variants as Production Ramps Up Ahead of 2027 Launch 
GameStop Proposes $56 Billion eBay Acquisition in Bold Strategic Move 
Anthropic’s $1.5B AI Venture with Wall Street Firms Targets Private Equity Market 
Supermicro Forecasts Strong Q4 Revenue Growth as AI Server Demand Surges 
Strategy Hints at Bitcoin Sales to Cover Dividends After Massive Q1 Loss 
Continental AG Shares Jump After Q1 Profit Beats Expectations 
Pinterest Stock Surges After Strong Q1 2026 Earnings Beat Expectations 
Strategy Reports Q1 Loss as Bitcoin Holdings Trigger $14.46 Billion Unrealized Hit 
Novo Nordisk Raises 2026 Outlook on Strong Wegovy Demand 
Meta Plans $13B AI Data Center Financing in Texas Amid Surging Big Tech Investment 
Volvo Car Sales Drop 10% in Early 2026 Despite Growth in Electric Vehicles 
Anthropic Secures $1.5B AI Venture Backed by Wall Street Giants, Shaking Software Sector 
Middle East Conflict Impacts Australia and New Zealand Businesses 
Hugo Boss Beats Q1 Profit Expectations Despite Market Headwinds 
DALLAS, May 03, 2018 -- via OTC PR WIRE--Puration, Inc. (USOTC:PURA) today released an image of the packaging design for THCSavor, the THC infused beverage the company has planned for production in Canada in conjunction with a previously announced pending acquisition intended to establish a cannabis cultivation operation for the recreational marijuana market expected to be legalized nationwide in Canada this summer.
|
|||||
“This packaging is a work in progress,” Said Brian Shibley, CEO of Puration. “Feel free to email us and tell us what you think. I’m enthusiastic about our new partners in Canada and look forward to sharing more details with you after we close the Canadian acquisition.”
Puration has scheduled a shareholder presentation for, Thursday next week, on May 10th, to provide overall details on the Canadian business acquisition expected to be closed as early as the end of this week. Highlights of the THCSavor go-to-market plan are to be included in the upcoming shareholder presentation.
For more information on Puration, visit http://www.aciconglomerated.com.
Disclaimer/Safe Harbor:
This news release contains forward-looking statements within the meaning of the Securities Litigation Reform Act. The statements reflect the Company's current views with respect to future events that involve risks and uncertainties. Among others, these risks include the expectation that any of the companies mentioned herein will achieve significant sales, the failure to meet schedule or performance requirements of the companies' contracts, the companies' liquidity position, the companies' ability to obtain new contracts, the emergence of competitors with greater financial resources and the impact of competitive pricing. In the light of these uncertainties, the forward-looking events referred to in this release might not occur. These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.
Puration, Inc.
Brian Shibley,
[email protected]
+1-800-861-1350
A photo accompanying this announcement is available at http://resource.globenewswire.com/Resource/Download/e769673c-f1aa-43fe-83dd-011a22393299
